Followers | 644 |
Posts | 38176 |
Boards Moderated | 1 |
Alias Born | 03/29/2003 |
Tuesday, August 15, 2017 1:01:05 AM
To Be Held at 10:00 a.m. local time on August 30, 2017
http://ih.advfn.com/p.php?pid=nmona&article=75441726&symbol=SGBY
Article Reads:
(1) To approve an amendment to our Restated and Amended Articles of Incorporation (“Charter”), at the discretion of our Board of Directors (the “Board”), to change the name of the Company to “EVIO, Inc.” (the “Name Change”);
(2) To approve an amendment to our Charter to reduce the number of authorized shares of common stock from 3,000,000,000 to 1,000,000,000, subject to the Board’s discretion to abandon such amendment at any time within 12 months following the Special Meeting; and authorize any other action deemed by our Board to be necessary in connection therewith, all without further approval or authorization of our shareholders (the “Authorized Share Reduction”);
(3) To approve an amendment to our Charter to effect a reverse stock split of all of the outstanding shares of our common stock at a ratio between one-for-100 and one-for-250, to be determined at the sole discretion of our Board, subject to the Board’s discretion to abandon such amendment at any time within 12 months following the Special Meeting; and authorize any other action deemed by our Board to be necessary in connection therewith, all without further approval or authorization of our shareholders (the “Reverse Split”);
(4) To authorize an amendment to our Charter to provide that any action of shareholders that would otherwise require a shareholders’ meeting may be taken by the written consent of the required minimum number of shareholders without a meeting pursuant to Section 7-107-104 of the Colorado Revised Statutes (the “Written Consent Authorization”); and
(5) To approve the adjournment of the Special Meeting, if necessary, to continue to solicit votes on the above proposals.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM